Copperwynd Financial, LLC Biogen Inc. Transaction History

Copperwynd Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$275.25 - $318.06 $1.72 Million - $1.99 Million	6,250 New	6,250 $1.78 Million
Q4 2022 Feb 02, 2023	BUY	$252.44 - $306.72 $1.61 Million - $1.96 Million	6,389 New	6,389 $1.77 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $347,809 - $454,838	-1,185 Closed	0 $0
Q2 2018 Aug 01, 2018	BUY	$257.52 - $306.91 $8,755 - $10,434	34 Added 2.95%	1,185 $344,000
Q1 2018 Apr 27, 2018	BUY	$260.13 - $367.91 $34,857 - $49,299	134 Added 13.18%	1,151 $315,000
Q4 2017 Feb 06, 2018	BUY	$307.64 - $344.58 $312,869 - $350,437	1,017	1,017 $324,000

993

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Copperwynd Financial, LLC with notifications on news.